Incidence, clinical presentation and pathological features of benign sclerosing cholangitis of unknown origin masquerading as biliary carcinoma

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 2, 2010, Pages 139-146

  Fujita, Takeo ^a   Kojima, Motohiro ^a   Gotohda, Naoto ^a   Takahashi, Shinichiro ^a   Nakagohri, Toshio ^a   Konishi, Masaru ^a   Ochiai, Atsushi ^a   Kinoshita, Taira ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Hilar cholangiocarcinoma; IgG4 associated sclerosing pancreatocholangitis; Malignant hilar masquerade; Sclerosing cholangitis

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN G;

ADULT; AGED; ANAPHYLACTOID PURPURA; ARTICLE; BENIGN SCLEROSING CHOLANGITIS OF UNKNOWN ORIGIN; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILIARY TRACT SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LIVER FAILURE; LYMPH FOLLICLE; LYMPHOCYTIC INFILTRATION; MALE; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; BILE DUCT; BILE DUCT TUMOR; CHOLECYSTECTOMY; CHOLESTASIS; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; JAPAN; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS; CHOLANGITIS, SCLEROSING; CHOLECYSTECTOMY; CHOLESTASIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INCIDENCE; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77956986982     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0115-5     Document Type: Article

References (30)

1. Hadjis NS, Collier NA, Blumgart LH. Malignant masquerade at the hilum of the liver. Br J Surg. 1985;72:659-61. (Pubitemid 15047629)
2. Are C, Gonen M, D'Angelica M, DeMatteo RP, Fong Y, Blumgart LH, et al. Differential diagnosis of proximal biliary obstruction. Surgery. 2006;140:756-63. (Pubitemid 44648190)
3. Corvera CU, Blumgart LH, Darvishian F, Klimstra DS, DeMatteo R, Fong Y, et al. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg. 2005;201:862-9. (Pubitemid 41689315)
4. Erdogan D, Kloek JJ, ten Kate FJ, Rauws EA, Busch OR, Gouma DJ, et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg. 2008;95:727-34.
5. Gerhards MF, Vos P, van Gulik TM, Rauws EA, Bosma A, Gouma DJ. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg. 2001;88:48-51. (Pubitemid 32066056)
6. Verbeek PC, van Leeuwen DJ, de Wit LT, Reeders JW, Smits NJ, Bosma A, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery. 1992;112:866-71.
7. Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg. 1991;161:57-62. Discussion 62-3.
8. Nakayama A, Imamura H, Shimada R, Miyagawa S, Makuuchi M, Kawasaki S. Proximal bile duct stricture disguised as malignant neoplasm. Surgery. 1999;125:514-21. (Pubitemid 29226923)
9. Lazaridis KN. Sclerosing cholangitis epidemiology and etiology. J Gastrointest Surg. 2008;12:417-9.
10. Kelly P, Patchett S, McCloskey D, Alstead E, Farthing M, Fairclough P. Sclerosing cholangitis, race and sex. Gut. 1997;41:688-9. (Pubitemid 27496151)
11. Zen Y, Kitagawa S, Minato H, Kurumaya H, Katayanagi K, Masuda S, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol. 2005;36:710-7. (Pubitemid 41112024)
12. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-8. (Pubitemid 32204991)
13. Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology. 2006;6:132-7.
14. Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: Part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc. 2005;62:152-7. (Pubitemid 40922461)
15. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol. 2004;39:1154-8. (Pubitemid 39536407)
16. Kloppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T. Autoimmune pancreatitis: Histo-and immunopathological features. J Gastroenterol. 2007;42 Suppl 18:28-31. (Pubitemid 46863934)
17. Kojima M, Sipos B, Klapper W, Frahm O, Knuth HC, Yanagisawa A, et al. Autoimmune pancreatitis: Frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol. 2007;31:521-8. (Pubitemid 46569035)
18. Yasuda H, Takada T, Kawarada Y, Nimura Y, Hirata K, Kimura Y, et al. Unusual cases of acute cholecystitis and cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14:98-113. (Pubitemid 46189148)
19. Gossard AA, Angulo P, Lindor KD. Secondary sclerosing cholangitis: A comparison to primary sclerosing cholangitis. Am J Gastroenterol. 2005;100:1330-3. (Pubitemid 40904357)
20. Kram MT, May LD, Cooperman A, Bernstein S, Abedeer R, Cohen PR. Lymphoplasmacytic sclerosing pancreatitis and cholangitis. Gastrointest Endosc. 2002;55:588-90. (Pubitemid 41123520)
21. Kamisawa T, Okamoto A, Wakabayashi T, Watanabe H, Sawabu N. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterol. 2008;43:609-13. (Pubitemid 351536059)
22. Nakanuma Y, Zen Y. Diagnosis of sclerosing bile duct lesions. Nippon Shokakibyo Gakkai Zasshi. 2006;103(12):1325-32.
23. Kajiwara M, Gotohda N, Konishi M, Nakagohri T, Takahashi S, Kojima M, et al. Incidence of the focal type of autoimmune pancreatitis in chronic pancreatitis suspected to be pancreatic carcinoma: Experience of a single tertiary cancer center. Scand J Gastroenterol. 2008;43:110-6.
24. Esposito I, Born D, Bergmann F, Longerich T, Welsch T, Giese NA, et al. Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: A comparative morphological and immunological analysis. PLoS ONE 2008;3:e2539.
25. Uhlmann D, Wiedmann M, Schmidt F, Kluge R, Tannapfel A, Berr F, et al. Management and outcome in patients with Klatskinmimicking lesions of the biliary tree. J Gastrointest Surg. 2006;10:1144-50. (Pubitemid 44349073)
26. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003;125:1364-9. (Pubitemid 37409756)
27. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 1995;332:924-33.
28. Feld JJ, Heathcote EJ. Epidemiology of autoimmune liver disease. J Gastroenterol Hepatol. 2003;18:1118-28. (Pubitemid 37410040)
29. Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100(5 Pt 1):1319-23.
30. Nakanuma Y, Zen Y. Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family. Hepatol Res. 2007;37(Suppl 3):S478-86. (Pubitemid 47570663)